VATE vs ACA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 27, 2026

VATE

54.8
AI Score
VS
VATE Wins

ACA

53.6
AI Score

Investment Advisor Scores

VATE

55score
Recommendation
HOLD

ACA

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric VATE ACA Winner
Forward P/E 4.8591 36.1011 VATE
PEG Ratio 0 2.2544 Tie
Revenue Growth 33.0% 4.4% VATE
Earnings Growth 0.0% 57.8% ACA
Tradestie Score 54.8/100 53.6/100 VATE
Profit Margin -4.0% 7.7% ACA
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

VATE 1M: -51.1% · 3M: -32.3% ACA 1M: +0.4% · 3M: +14.8%

Current Technical Phase

VATE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.9%), weak momentum, RSI 29

RSI (14): 29.5 · Price: $8.12

ACA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.4% over 20 days), RSI 66

RSI (14): 66.1 · Price: $145.20

Fundamentals Snapshot

Metric VATE ACA
Market Cap
Forward P/E 4.9 28.6
Trailing P/E 32.4
Revenue (TTM)
Revenue Growth 0.3% 0.0%
Gross Margin 0.2% 0.2%
Operating Margin 0.0% 0.1%
EPS -4.24 4.48
Dividend Yield 0.00% 0.00%

Frequently Asked Questions

Based on our detailed analysis, VATE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.